Thermo Fisher Scientific (FRA:TN80) Cyclically Adjusted Revenue per Share: €2.19 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:TN80 Thermo Fisher Scientific Inc FRA:TN80
67 GF Score
Price €12.10
GF Value €12.43
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Thermo Fisher Scientific Cyclically Adjusted Revenue per Share?

Thermo Fisher Scientific FRA:TN80 +0.83% 67 Cyclically Adjusted Revenue per Share is €2.19 as of Jun. 2026. GuruFocus rates FRA:TN80 with a GF Score™ of 67/100 and a GF Value™ of €12.43 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Thermo Fisher Scientific's adjusted revenue per share for the three months ended in Jun. 2026 was €0.764. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €2.19 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Thermo Fisher Scientific's average Cyclically Adjusted Revenue Growth Rate was 10.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 12.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Thermo Fisher Scientific was 16.50% per year. The lowest was -1.30% per year. And the median was 9.50% per year.

As of today (2026-07-30), Thermo Fisher Scientific's current stock price is €12.10. Thermo Fisher Scientific's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €2.19. Thermo Fisher Scientific's Cyclically Adjusted PS Ratio of today is 5.53.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Thermo Fisher Scientific was 10.98. The lowest was 4.16. And the median was 6.43.


Thermo Fisher Scientific  (FRA:TN80) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Thermo Fisher Scientific's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=12.10/2.19
=5.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Thermo Fisher Scientific was 10.98. The lowest was 4.16. And the median was 6.43.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Thermo Fisher Scientific Cyclically Adjusted Revenue per Share Related Terms


Thermo Fisher Scientific Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Thermo Fisher Scientific's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thermo Fisher Scientific Cyclically Adjusted Revenue per Share Chart

Thermo Fisher Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 2.13 2.10

Thermo Fisher Scientific Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.09 2.10 2.10 2.13 2.19

FRA:TN80 vs DHR, IDXX, A: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thermo Fisher Scientific Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Thermo Fisher Scientific's Cyclically Adjusted PS Ratio falls into.


FRA:TN80
67GF Score
Thermo Fisher Scientific Inc FRA:TN80
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thermo Fisher Scientific Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Thermo Fisher Scientific's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.764/333.9520*333.9520
=0.764

Current CPI (Jun. 2026) = 333.9520.

Thermo Fisher Scientific Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.274 241.428 0.379
201612 0.323 241.432 0.447
201703 0.308 243.801 0.422
201706 0.308 244.955 0.420
201709 0.292 246.819 0.395
201712 0.344 246.524 0.466
201803 0.318 249.554 0.426
201806 0.349 251.989 0.463
201809 0.340 252.439 0.450
201812 0.384 251.233 0.510
201903 0.366 254.202 0.481
201906 0.378 256.143 0.493
201909 0.384 256.759 0.499
201912 0.415 256.974 0.539
202003 0.384 258.115 0.497
202006 0.420 257.797 0.544
202009 0.494 260.280 0.634
202012 0.592 260.474 0.759
202103 0.571 264.877 0.720
202106 0.529 271.696 0.650
202109 0.544 274.310 0.662
202112 0.650 278.802 0.779
202203 0.740 287.504 0.860
202206 0.717 296.311 0.808
202209 0.744 296.808 0.837
202212 0.751 296.797 0.845
202303 0.702 301.836 0.777
202306 0.692 305.109 0.757
202309 0.695 307.789 0.754
202312 0.701 306.746 0.763
202403 0.675 312.332 0.722
202406 0.696 314.175 0.740
202409 0.677 315.301 0.717
202412 0.774 315.605 0.819
202503 0.689 319.799 0.719
202506 0.678 322.561 0.702
202509 0.683 324.800 0.702
202512 0.752 324.054 0.775
202603 0.695 330.213 0.703
202606 0.764 333.952 0.764

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €2.19 mean?
Thermo Fisher Scientific (FRA:TN80) has a Cyclically Adjusted Revenue per Share of €2.19 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Thermo Fisher Scientific and its competitors.
Is Thermo Fisher Scientific's Cyclically Adjusted Revenue per Share too high?
Thermo Fisher Scientific's current Cyclically Adjusted Revenue per Share is €2.19. Overall, Thermo Fisher Scientific has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's Cyclically Adjusted Revenue per Share compare to DHR and IDXX?
Thermo Fisher Scientific's Cyclically Adjusted Revenue per Share of €2.19 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Thermo Fisher Scientific and its competitors. Thermo Fisher Scientific's current Cyclically Adjusted Revenue per Share is €2.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (FRA:TN80) is currently considered Fairly Valued. The stock's GF Value™ is €12.43, compared to a current price of €12.10 — trading 2.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €2.19. Thermo Fisher Scientific's overall GF Score™ is 67/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Thermo Fisher Scientific (FRA:TN80), the current Cyclically Adjusted Revenue per Share is €2.19 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thermo Fisher Scientific (FRA:TN80) Overvalued in 2026?

Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be undervalued. The current stock price of €12.10 is trading 2.7% below its estimated GF Value™ of €12.43. GuruFocus considers Thermo Fisher Scientific to be Fairly Valued.

Key valuation signals for FRA:TN80:

  • Cyclically Adjusted Revenue per Share: €2.19
  • GF Value™: €12.43 vs. price of €12.10 (2.7% below fair value)
  • GF Score™: 67/100 with 8 warning signs

No single metric tells the full story. See the FRA:TN80 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Thermo Fisher Scientific Business Description

Address 168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
67GF Score

Get the complete analysis for FRA:TN80

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.10
Price
€12.43
GF Value